medline.ch Onkologie Gynäkologische Tumoren

	Global Assessment of the Relationship Between Breast Cancer Risk and Dietary Intake: An Ecological Study. Am J Health Promot Lamchabbek N, Huybrechts I, El Badisy I, El Kouzzib S, Benajiba N, Faure E, Khalis M. PMID: 41221982 [PubMed - as supplied by publisher]
	A comprehensive review on recent developments in near-infrared organic fluorophores for breast cancer: from molecular design to diagnostic applications. J Mater Chem B Murugan P, Praburaman L, Singaravel V, Moovendhan M, Peng YL, Yang F, Liu SY. PMID: 41221586 [PubMed - as supplied by publisher]
	Unraveling the genetic links between obesity or insulin resistance and breast cancer through the impact of CD295 and ITLN1 SNPs with DNA damage in a case-controlled study with bioinformatics analysis. Front Med (Lausanne) Hamdy NM, Mosaad YO, Elshimy R, Hady AA, Lin Q, Jastaniah Z, Amjad R, Altoukhi H, Almarzouki H, Abdelsamad A, El Magdoub HM, Fathi D. PMID: 41221514 [PubMed - in process]
	The impact of mind-body exercise on female breast cancer patients-a systematic review and meta-analysis of randomized controlled trials. Front Public Health Li L, He Y, Yang X, Liu Y. PMID: 41221238 [PubMed - in process]
	Metronomic Chemotherapy in Breast Cancer: Unleashing the Potential of Combination Regimens. Cancer Innov Liu J, Mo H, Li Q, Cazzaniga ME, Ma F. PMID: 41221152 [PubMed - in process]
	Drug repurposing of natural depsipeptide from Eleftheria terrae isolated via iChip for anti-breast cancer therapy. Front Pharmacol Fhatonah N, Rustandi T, Abdelmohsen UR, Rasydy OA, Ma'sum, Elghanam Y, Pashar I, Nordin, Mahal A, Riski A. PMID: 41221054 [PubMed - in process]
	Stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (OMOC): a systematic review and meta-analysis of clinical outcomes and toxicity profiles. Front Pharmacol Maiorano MFP, Maiorano BA. PMID: 41221047 [PubMed - in process]
	Diagnostic performance of a radiological Fagotti score assessed on diffusion-weighted magnetic resonance imaging for predicting tumor resectability in ovarian cancer patients: a feasibility study. Front Oncol Siegenthaler F, Zurbriggen S, Wyss C, Imboden S, Saner F, Wampfler J, Christe L, Solass W, Hofer S, Christe A, Heverhagen JT, Mueller MD, Obmann VC. PMID: 41220950 [PubMed - in process]
	Randomized pilot study of an individualized multimodal exercise, nutrition, and behavior intervention in breast cancer patients treated with ovarian function suppression: protocol proposal for The OvS Breast ENBI Project. Front Oncol Herrero López B, Castellanos Montealegre M, Soulas C, Rufrancos BA, García-Ontiveros Cuéllar ML, Del Monte Millán M, Villarejo López L, López-Tarruella Cobo S, Jerez Gilarranz Y, Echavarría Díaz-Guardamino I, Jara P, Jiménez MM, Sánchez TM, Martínez Beltrán MJ, de la Torre Montero JC, Casla Barrio S. PMID: 41220947 [PubMed - in process]
	A Predictive Model Based on Machine Learning Algorithm for Vein Thrombosis After Ovarian Cancer Resection. Int J Womens Health Zhao L, Yao L. PMID: 41220622 [PubMed - in process]
	Use of (18)F-fluorodeoxyglucose positron emission tomography coupled with computed tomography in early breast cancer management: consensus-based local recommendations by the Hong Kong Breast Cancer Foundation PET/CT Study Group. Hong Kong Med J Kwok CCH, Wong HCY, Wong CYH, Yuen LW, Yau CC, Cheung PSY. PMID: 41220140 [PubMed - as supplied by publisher]
	Redefining the Diagnostic Threshold for Breast Cancer-related Lymphedema. Ann Surg Wagner BD, Barrio AV, Coriddi MR, Rubin J, Boe LA, Shammas RL, Levy J, Hespe GE, Yoshimatsu H, Rockson SG, Mehrara BJ. PMID: 41220050 [PubMed - as supplied by publisher]
	TCGA molecular subtypes in endometriosis-associated ovarian cancer: a systematic review and meta-analysis. Ann Med Ye L, Chen J, Guo W, Zhao Q, Cheng X, Wang X, Xu X, Chen X, Ni J. PMID: 41220042 [PubMed - in process]
	Radiomics and radiogenomics in ovarian cancer: a review with a focus on ultrasound applications. Cancer Imaging Huang Y, Peng W, Yang H, Liu Z, Zhang T, Jin L, He W, Du M, Chen Z. PMID: 41220029 [PubMed - in process]
	Decoding the mechanisms underlying breast cancer brain metastasis: paving the way for precision therapeutics. Biomark Res Zhang X, Wang X, Shi S, Guo D. PMID: 41219968 [PubMed - in process]
	Predicting breast cancer response to neoadjuvant therapy by integrating radiomic and deep-learning features from early-and-peak phases of DCE-MRI. BMC Cancer Zhang Y, Cai J, Cui C, Qi S, Zhao D. PMID: 41219899 [PubMed - in process]
	The role and prognostic value of mitochondria-related gene PARK7 in breast cancer. Breast Cancer Res Yu S, Zhou Y, Zhang S, He F, Jiang L, Lv X, Gu X, Xie X. PMID: 41219819 [PubMed - in process]
	Therapeutic targeting of post-translational modifications in ovarian cancer: mechanisms and clinical applications. J Ovarian Res Ke L, Zhang Y. PMID: 41219748 [PubMed - in process]
	Whole-exome sequencing of FFPE samples reveals mutations associated with Luminal A breast cancer recurrence. BMC Biotechnol Lv K, Chen Y, Zhou J, Ji F, Hu W. PMID: 41219734 [PubMed - in process]
	Effects of occupational therapy in return-to-family intervention on upper limb, shoulder function, and role function in breast cancer patients: a multicenter randomized controlled trial. Support Care Cancer Song P, Li R, Liu JE, Liu L, Liu J. PMID: 41219574 [PubMed - in process]

Artikel 1 - 20 / 317178

Seite 1 von 15859

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung